Abstract

Fractal dimension, a measure of self-similarity in a structure, is a powerful physical parameter for the characterization of structural property of many partially filled disordered materials. Biological tissues are fractal in nature and reports show a change in self-similarity associated with the progress of cancer, resulting in changes in their fractal dimensions. Here, we report that fractal dimension measurement is a potential technique for the detection of different stages of cancer using transmission optical microscopy. Transmission optical microscopy of a thin tissue sample produces intensity distribution patterns proportional to its refractive index pattern, representing its mass density distribution. We measure fractal dimension detection of different cancer stages and find its universal feature. Many deadly cancers are difficult to detect in their early to different stages due to the hard-to-reach location of the organ and/or lack of symptoms until very late stages. To study these deadly cancers, tissue microarray (TMA) samples containing different stages of cancers are analyzed for pancreatic, breast, colon, and prostate cancers. The fractal dimension method correctly differentiates cancer stages in progressive cancer, raising possibilities for a physics-based accurate diagnosis method for cancer detection.

Highlights

  • An object exhibiting self-similar structures at different length scales is known as a fractal

  • The fractal dimension analysis tool in Image J is used to calculate the fractal dimension of each cancer stage of tissue microarray (TMA) samples, which are graphed for comparison

  • We explored the possibility of creating a standardized, physics-based cancer diagnosis test capable of accurate detection of cancer in both early and late stages based on the fractal dimension analysis of paraffin embedded TMA samples

Read more

Summary

Introduction

An object exhibiting self-similar structures at different length scales is known as a fractal. Biological tissues have spatial heterogeneity in their mass density distribution and are a self-similar structure. This self-similar structure can be analyzed and expressed in terms of fractal dimension. The fractal dimension of an object is a number quantifying how similar the structure remains with changes in length scale and is related to the structural porosity of the tissue samples. A tissue’s fractal dimension will change throughout the course of cancer progression due to the increased production and rearrangement of intracellular structures such as DNA, RNA, lipids, heterochromatin, and the extracellular matrix, which causes an increase in the mass density and rearrangement of the tissue. Several reports are measuring fractal dimensions for cancer detection, they are mainly individual cancer cases and the topic requires more exploration [6,10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call